ACR COVID-19 Clinical Guidance Town Hall
On May 6, the ACR hosted a virtual town hall to discuss the recently published COVID-19 Clinical Guidance for Adult Patients with Rheumatic Diseases. Panelists and moderators discussed the guidance recommendations and answered a number of questions submitted by attendees. Watch the complete event
HHS Announces Additional Allocations to Relief Fund
The Department of Health and Human Services (HHS) has announced details on remaining allocations of the Provider Relief Fund created by the CARES Act. An additional $20 billion has been designated for general distribution to Medicare facilities and providers impacted by COVID-19. Unlike the initial tranche of funding from the HHS, most eligible practices will need to complete the application before funds are approved and sent to their bank account. HHS Announces Additional Allocations to Relief Fund
COVID-19 CARES Act Package Additional Funds Summary
On April 21, the Senate passed legislation injecting additional funds in the CARES Act. The House is predicted to vote to pass the package on April 23. Read more about what was included in the package, and ask Congress to preserve patient access by supporting provider solvency.
See All Breaking News
In response to the recently published COVID-19 Clinical Guidance for Adult Patients with Rheumatic Diseases, the ACR hosted a virtual town hall on May 6 for the rheumatology community to review the recommendations. ACR President Ellen Gravallese, MD, and ACR Secretary, Kenneth Saag, MD, MSc, served as co-moderators for the discussion.
Ted Mikuls, MD, MSPH
Bonnie Bermas, MD
Stanley Cohen, MD, MACR
Karen Costenbader, MD, MPH
Michael Weinblatt, MD, MACR
Kevin Winthrop, MD, MPH
Practice and Advocacy Resources
The ACR’s COVID-19 Practice and Advocacy Task Force continues to work rapidly to provide support to you during this unprecedented time. You’ll find guidance documents that include approaches to drug shortages, support for telehealth, information about federal stimulus relief aid, and guidance for infusions. Working with experts in COVID-related topics, we are focused on developing meaningful information and resources to help guide you.
Clinical Guidance for Adult Patients with Rheumatic Diseases
The ACR has developed clinical guidance for the care of adult patients with rheumatic diseases during the COVID-19 pandemic. Populations considered include patients with a documented COVID-19 infection, those who are stable following exposure to SARS-CoV-2 (but without known infection), and patients who are stable with no infection or exposure. The recommendations address various treatment options and provide general guidance, as well as direction for when to start, stop, or reduce medications. All recommendations are based on current knowledge and will be revised as circumstances and evidence evolve.
How to cite this article: Mikuls TR, Johnson SR, Fraenkel L, Arasaratnam RJ, Baden LR, Bermas BL, et al. American College of Rheumatology guidance for the management of adult patients with rheumatic disease during the COVID-19 pandemic. Arthritis Rheumatol doi: https://onlinelibrary.wiley.com/doi/abs/10.1002/art.41301. E-pub ahead of print.
You can also access the clinical guidance information on your iOS or Android mobile device. Download the free ACR Guideline and Criteria App on the App Store or Google Play.
Global Rheumatology Alliance
The COVID-19 Global Rheumatology Alliance, a section of the American College of Rheumatology, is a provider-entered registry aiming to collect data on rheumatology patients with COVID-19 and hopes the information will provide guidance for rheumatology professionals when assessing and treating the infection in patients with rheumatic disease.
Experiencing COVID-19 related drug shortages, practice issues, or any other problems?
Share your comments and questions with us at COVID@rheumatology.org
Updated May 20, 2020 at 9:45 AM ET